A review of coverage of our peer-reviewed research, in the mainstream and healthcare press.
Two articles in the new issue of The American Journal of Managed Care are gaining notice in the healthcare press this week. David Salazar of DrugStore News was among those who wrote about “The Impact of Formulary Drug Exclusion Policies on Patients and Heatlhcare Costs,” which is a review 26 studies. The article, by researchers at the Tufts Medical Center’s Institute for Clinical Research and Health Policy Studies, in the Center for the Evaluation of Value and Risk in Health, found that while there are exceptions, most research shows that exclusions save money without harming patients.
The article, “Opinions on the Hospital Readmission Reduction Program: Results of a National Survey of Hospital Leaders,” drew plenty of reader and press interest. Jacqueline Belliveau of RevenueCycle Intelligence covered the results of the survey, which found that two-thirds of respondents feel CMS’ financial penalties for not meeting 30-day readmission targets are having a major effect on their efforts to decrease readmissions. The authors, from Harvard’s T.H. Chan School of Public Health, also found that three-quarter of the leaders faulted CMS for failing to account for differences in the socioeconomic mix of hospital populations.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen